These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16828746)

  • 1. Evaluation and lead optimization of anti-malarial acridones.
    Winter RW; Kelly JX; Smilkstein MJ; Dodean R; Bagby GC; Rathbun RK; Levin JI; Hinrichs D; Riscoe MK
    Exp Parasitol; 2006 Sep; 114(1):47-56. PubMed ID: 16828746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum.
    Kelly JX; Smilkstein MJ; Cooper RA; Lane KD; Johnson RA; Janowsky A; Dodean RA; Hinrichs DJ; Winter R; Riscoe M
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4133-40. PubMed ID: 17846138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro efficiency of new acridyl derivatives against Plasmodium falciparum.
    Guetzoyan L; Ramiandrasoa F; Dorizon H; Desprez C; Bridoux A; Rogier C; Pradines B; Perrée-Fauvet M
    Bioorg Med Chem; 2007 May; 15(9):3278-89. PubMed ID: 17339112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activities of new acridone alkaloid derivatives against Plasmodium yoelii in vitro.
    Fujioka H; Kato N; Fujita M; Fujimura K; Nishiyama Y
    Arzneimittelforschung; 1990 Sep; 40(9):1026-9. PubMed ID: 2080937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acridone and furoquinoline alkaloids from Teclea gerrardii (Rutaceae: Toddalioideae) of southern Africa.
    Waffo AF; Coombes PH; Crouch NR; Mulholland DA; El Amin SM; Smith PJ
    Phytochemistry; 2007 Mar; 68(5):663-7. PubMed ID: 17174364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parallel synthesis of 9-aminoacridines and their evaluation against chloroquine-resistant Plasmodium falciparum.
    Anderson MO; Sherrill J; Madrid PB; Liou AP; Weisman JL; DeRisi JL; Guy RK
    Bioorg Med Chem; 2006 Jan; 14(2):334-43. PubMed ID: 16216519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships of novel anti-malarial agents: 1. arylacyl and cyclohexylacyl derivatives of 5-amino-2-tolylacetylaminobenzophenone.
    Wiesner J; Mitsch A; Wissner P; Jomaa H; Schlitzer M
    Pharmazie; 2001 Jun; 56(6):443-4. PubMed ID: 11446161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acridinediones: selective and potent inhibitors of the malaria parasite mitochondrial bc1 complex.
    Biagini GA; Fisher N; Berry N; Stocks PA; Meunier B; Williams DP; Bonar-Law R; Bray PG; Owen A; O'Neill PM; Ward SA
    Mol Pharmacol; 2008 May; 73(5):1347-55. PubMed ID: 18319379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of 1,2,3,4-tetrahydroacridin-9(10H)-ones as antimalarials utilizing structure-activity and structure-property relationships.
    Cross RM; Maignan JR; Mutka TS; Luong L; Sargent J; Kyle DE; Manetsch R
    J Med Chem; 2011 Jul; 54(13):4399-426. PubMed ID: 21630666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and Structural Optimization of Acridones as Broad-Spectrum Antimalarials.
    Dodean RA; Kancharla P; Li Y; Melendez V; Read L; Bane CE; Vesely B; Kreishman-Deitrick M; Black C; Li Q; Sciotti RJ; Olmeda R; Luong TL; Gaona H; Potter B; Sousa J; Marcsisin S; Caridha D; Xie L; Vuong C; Zeng Q; Zhang J; Zhang P; Lin H; Butler K; Roncal N; Gaynor-Ohnstad L; Leed SE; Nolan C; Huezo SJ; Rasmussen SA; Stephens MT; Tan JC; Cooper RA; Smilkstein MJ; Pou S; Winter RW; Riscoe MK; Kelly JX
    J Med Chem; 2019 Apr; 62(7):3475-3502. PubMed ID: 30852885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of acridinyl hydrazides as potent aspartic protease inhibitors.
    Azim MK; Ahmed W; Khan IA; Rao NA; Khan KM
    Bioorg Med Chem Lett; 2008 May; 18(9):3011-5. PubMed ID: 18417344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-malarial activity of new N-acetyl-L-leucyl-L-leucyl-L-norleucinal (ALLN) derivatives against Plasmodium falciparum.
    Choi HJ; Cui M; Li DY; Song HO; Kim HS; Park H
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1293-6. PubMed ID: 23357632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein farnesyltransferase inhibitors exhibit potent antimalarial activity.
    Nallan L; Bauer KD; Bendale P; Rivas K; Yokoyama K; Hornéy CP; Pendyala PR; Floyd D; Lombardo LJ; Williams DK; Hamilton A; Sebti S; Windsor WT; Weber PC; Buckner FS; Chakrabarti D; Gelb MH; Van Voorhis WC
    J Med Chem; 2005 Jun; 48(11):3704-13. PubMed ID: 15916422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of a new class of 4-aminoquinolinyl- and 9-anilinoacridinyl Schiff base hydrazones as potent antimalarial agents.
    Sharma M; Chauhan K; Srivastava RK; Singh SV; Srivastava K; Saxena JK; Puri SK; Chauhan PM
    Chem Biol Drug Des; 2014 Aug; 84(2):175-81. PubMed ID: 24444074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and structure-activity relationship studies of 4-quinolinyl- and 9-acrydinylhydrazones as potent antimalarial agents.
    Fattorusso C; Campiani G; Kukreja G; Persico M; Butini S; Romano MP; Altarelli M; Ros S; Brindisi M; Savini L; Novellino E; Nacci V; Fattorusso E; Parapini S; Basilico N; Taramelli D; Yardley V; Croft S; Borriello M; Gemma S
    J Med Chem; 2008 Mar; 51(5):1333-43. PubMed ID: 18278859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of acridine derivatives as antimalarial agents.
    Yu XM; Ramiandrasoa F; Guetzoyan L; Pradines B; Quintino E; Gadelle D; Forterre P; Cresteil T; Mahy JP; Pethe S
    ChemMedChem; 2012 Apr; 7(4):587-605. PubMed ID: 22331612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel pantothenate derivatives for anti-malarial chemotherapy.
    Pett HE; Jansen PA; Hermkens PH; Botman PN; Beuckens-Schortinghuis CA; Blaauw RH; Graumans W; van de Vegte-Bolmer M; Koolen KM; Rutjes FP; Dechering KJ; Sauerwein RW; Schalkwijk J
    Malar J; 2015 Apr; 14():169. PubMed ID: 25927675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationships of novel anti-malarial agents part 8. Effect of different central aryls in biarylacryloylaminobenzophenones on antimalarial activity.
    Wiesner J; Mitsch A; Altenkämper M; Ortmann R; Jomaa H; Schlitzer M
    Pharmazie; 2003 Dec; 58(12):854-6. PubMed ID: 14703959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmodium falciparum: the potential of the cancer chemotherapeutic agent cisplatin and its analogues as anti-malarials.
    Murray V; Campbell HM; Gero AM
    Exp Parasitol; 2012 Dec; 132(4):440-3. PubMed ID: 23000555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BDA-410: a novel synthetic calpain inhibitor active against blood stage malaria.
    Li X; Chen H; Jeong JJ; Chishti AH
    Mol Biochem Parasitol; 2007 Sep; 155(1):26-32. PubMed ID: 17583361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.